CanFaster- The translational cancer faster forward doctoral programme
The CanFaster program is supported by the European Union’s Marie Skłodowska-Curie programme, which is part of the Horizon 2020 framework and based on the "Mobility across boarders" philosophy.
The CanFaster programme aims to attract excellent international PhD candidates with an interest in applied medical research in oncology and entrepreneurship to Lund University, CREATE health and Medicon Village.The program build on collaboration between industry, healthcare and academia to strengthen and accelerate innovations and clinical implementation in oncology. The 16 PhD students will gain an understanding of unmet needs in the clinic and learn the mind-set of entrepreneurs in an upcoming PhD programme within cancer.
The programme will give the excellent PhD candidates the appropriate training, experience, and guidance to combine research with efforts to create innovations from it. A rich and comprehensive training programme is offered in combination with secondments in the non-academic sector, such as clinic or industry. The programme will result in a new type of entrepreneurship-PhDs with knowledge in innovations processes as well as start-up processes.
The young researchers - to be trained in an academic as well as non-academic setting - will become true innovators, enforced with a broad set of scientific, transferable, and business skills.
There will be one call, selecting 16 excellent PhD candidates, scheduled as follows: Opening of the call is September 2017 and the deadline for the submission of applications is November 2017.